Serum levels of the adipokine lipocalin-2 are increased in preeclampsia

Journal of Endocrinological Investigation

Volumn 33, Issue 9, 2010, Pages 629-632

  Stepan, H ^a   Philipp, A ^a   Reiche, M ^a   Klostermann, K ^a   Schrey, S ^a   Reisenbuchler C ^a   Lossner, U ^a   Kratzsch, J ^a   Bluher, M ^a   Stumvoll, M ^a   Fasshauer, M ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adipokine; Insulin resistance; Lipocalin 2; Obesity; Preeclampsia

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID METABOLISM; PREECLAMPSIA; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE-PHASE PROTEINS; ADIPOKINES; ADULT; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; KIDNEY FUNCTION TESTS; LIPOCALINS; MULTIVARIATE ANALYSIS; OSMOLAR CONCENTRATION; PRE-ECLAMPSIA; PREGNANCY; PROTO-ONCOGENE PROTEINS; YOUNG ADULT;

EID: 78751696505     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6884     Document Type: Article

References (26)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005, 365: 785-99.
2. Stepan H, Geide A, Faber R. Soluble fms-like tyrosine kinase 1. N Engl J Med 2004, 351: 2241-2.
3. Stepan H, Faber R. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med 2006, 354: 1857-8.
4. Stepan H, Walther T. Questionable role of the angiotensin ii receptor subtype 1 autoantibody in the pathogenesis of preeclampsia. Hypertension 2007, 50: e3.
5. Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007, 49: 818-24.
6. Poston L. Leptin and preeclampsia. Semin Reprod Med 2002, 20: 131-8.
7. Tommaselli GA, Pighetti M, Nasti A, et al. Serum leptin levels and uterine Doppler flow velocimetry at 20 weeks' gestation as markers for the development of pre-eclampsia. Gynecol Endocrinol 2004, 19: 160-5.
8. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998, 40: 102-11.
9. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 2005, 46: 1022-5.
10. Fasshauer M, Waldeyer T, Seeger J, et al. Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf) 2008, 69: 69-73.
11. Fasshauer M, Seeger J, Waldeyer T, et al. Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am J Hypertens 2008, 21: 582-6.
12. Fasshauer M, Waldeyer T, Seeger J, et al. Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. Eur J Endocrinol 2008, 158: 197-201.
13. Wang Y, Lam KS, Kraegen EW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007, 53: 34-41.
14. Yan QW, Yang Q, Mody N, et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007, 56: 2533-40.
15. Hemdahl AL, Gabrielsen A, Zhu C, et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006, 26: 136-42.
16. Flower DR, North AC, Attwood TK. Structure and sequence relationships in the lipocalins and related proteins. Protein Sci 1993, 2: 753-61.
17. Akerstrom B, Flower DR, Salier JP. Lipocalins: unity in diversity. Biochim Biophys Acta 2000, 1482: 1-8.
18. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436: 356-62.
19. Choi KM, Lee JS, Kim EJ, et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol 2008, 158: 203-7.
20. Stepan H, Ebert T, Schrey S, et al. Serum levels of angiopoietin-related growth factor are increased in preeclampsia. Am J Hypertens 2009, 22: 314-8.
21. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2007, 183: S1-22.
22. Wolf M, Hubel CA, Lam C, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004, 89: 6239-43.
23. D'Anna R, Baviera G, Giordano D, Todarello G, Corrado F, Buemi M. Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. Acta Obstet Gynecol Scand 2008, 87: 1370-3.
24. D'Anna R, Baviera G, Giordano D, et al. First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. Prenat Diagn 2009, 29: 1066-8.
25. Stejskal D, Karpisek M, Humenanska V, et al. Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA. Horm Metab Res 2008, 40: 381-5.
26. Sommer G, Weise S, Kralisch S, et al. Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitro. J Cell Biochem 2008, 106: 103-8.